Search

Your search keyword '"PROTEIN arginine methyltransferases"' showing total 1,414 results

Search Constraints

Start Over You searched for: Descriptor "PROTEIN arginine methyltransferases" Remove constraint Descriptor: "PROTEIN arginine methyltransferases"
1,414 results on '"PROTEIN arginine methyltransferases"'

Search Results

1. Discovery of PRMT3 Degrader for the Treatment of Acute Leukemia.

2. ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways.

3. The emerging role of CARM1 in cancer.

4. Assessing the Role of At GRP7 Arginine 141, a Target of Dimethylation by PRMT5, in Flowering Time Control and Stress Response.

5. SCR‐7952, a highly selective MAT2A inhibitor, demonstrates synergistic antitumor activities in combination with the S‐adenosylmethionine‐competitive or the methylthioadenosine‐cooperative protein arginine methyltransferase 5 inhibitors in methylthioadenosine phosphorylase‐deleted tumors

6. PRMT1 inhibition perturbs RNA metabolism and induces DNA damage in clear cell renal cell carcinoma.

7. Methylation of KSHV vCyclin by PRMT5 contributes to cell cycle progression and cell proliferation.

8. Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling.

9. Low methylthioadenosine phosphorylase expression is associated with worse survival in patients with acute myeloid leukaemia.

10. Histone Arginine Methylation as a Regulator of Gene Expression in the Dehydrating African Clawed Frog (Xenopus laevis).

11. BTG2 interference ameliorates high glucose-caused oxidative stress, cell apoptosis, and lipid deposition in HK-2 cells.

12. Role of protein arginine methyltransferase 1 in obesity‐related metabolic disorders: Research progress and implications.

13. Editorial: Conference research topic: 16th international symposium on schistosomiasis NEW ('th') presented in superscript.

14. Role of PRMT1 and PRMT5 in Breast Cancer.

15. Protein Arginine Methyltransferase CARM1 in Human Breast Cancer.

16. Targeting PRMT5 enhances the radiosensitivity of tumor cells grown in vitro and in vivo.

17. The Regulatory Impact of CFLAR Methylation Modification on Liver Lipid Metabolism.

18. Sustained cancer‐relevant alternative RNA splicing events driven by PRMT5 in high‐risk neuroblastoma.

19. HSV-1 reactivation results in post-herpetic neuralgia by upregulating Prmt6 and inhibiting cGAS-STING.

20. Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease.

21. Protein arginine methyltransferase 2 controls inflammatory signaling in acute myeloid leukemia.

22. Genome-wide identification and expression analysis of protein arginine methyltransferase and JmjC domain-containing family in apple.

23. A PRMT5-ZNF326 axis mediates innate immune activation upon replication stress.

24. Protein arginine methyltransferase 1 regulates mouse enteroendocrine cell development and homeostasis.

25. Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease.

26. The Discovery of Selective Protein Arginine Methyltransferase 5 Inhibitors in the Management of β-Thalassemia through Computational Methods.

27. Human C15orf39 Inhibits Inflammatory Response via PRMT2 in Human Microglial HMC3 Cell Line.

28. Trans-Activation of the Coactivator-Associated Arginine Methyltransferase 1 (Carm1) Gene by the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1.

29. CARM1 drives mitophagy and autophagy flux during fasting-induced skeletal muscle atrophy.

30. PRMT5: splicing up tolerance.

31. Epigenetic Regulation of Cardiomyocyte Maturation by Arginine Methyltransferase CARM1.

32. NEAT1 repression by MED12 creates chemosensitivity in p53 wild‐type breast cancer cells.

33. Tyrosine phosphorylation of CARM1 promotes its enzymatic activity and alters its target specificity.

34. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt–β-catenin pathway.

35. Protein Arginine Methyltransferases in Pancreatic Ductal Adenocarcinoma: New Molecular Targets for Therapy.

36. Protein arginine methyltransferase 1, a major regulator of biological processes.

37. Histone H4 asymmetrically dimethylated at arginine 3 (H4R3me2a), a mark of super-enhancers.

38. Genome-wide screening identifies Trim33 as an essential regulator of dendritic cell differentiation.

39. Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing.

40. Fibroblast-specific PRMT5 deficiency suppresses cardiac fibrosis and left ventricular dysfunction in male mice.

41. SISTER OF FCA physically associates with SKB1 to regulate flowering time in Arabidopsis thaliana.

42. PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.

43. Glioblastoma with PRMT5 gene upregulation is a key target for tumor cell regression.

44. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem Cells by Blocking the STAT3 Signaling Pathway.

45. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2 low Adult T-Cell Leukemia/Lymphoma.

46. Brg1/PRMT5 nuclear complex epigenetically regulates FOXO1 in IPF mesenchymal progenitor cells.

47. Pycard deficiency inhibits microRNA maturation and prevents neointima formation by promoting chaperone-mediated autophagic degradation of AGO2/argonaute 2 in adipose tissue.

48. PRMT5 activates KLF5 by methylation to facilitate lung cancer.

49. Editorial: Cancer genetics and epigenetics: theranostic targets and mechanisms.

50. The role of protein arginine N-methyltransferases in inflammation.

Catalog

Books, media, physical & digital resources